Jamil Azzi
Jamil Azzi
Unknown affiliation
Verified email at - Homepage
Cited by
Cited by
Calcineurin inhibitors: 40 years later, can’t live without…
JR Azzi, MH Sayegh, SG Mallat
The Journal of Immunology 191 (12), 5785-5791, 2013
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ...
Nature cancer 1 (5), 493-506, 2020
Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response
LL Cunha, SF Perazzio, J Azzi, P Cravedi, LV Riella
Frontiers in immunology 11, 553905, 2020
Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes
M Jurewicz, S Yang, A Augello, JG Godwin, RF Moore, J Azzi, P Fiorina, ...
Diabetes 59 (12), 3139-3147, 2010
Tixagevimab/cilgavimab pre‐exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave
A Al Jurdi, L Morena, M Cote, E Bethea, J Azzi, LV Riella
American Journal of Transplantation 22 (12), 3130-3136, 2022
CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor–based regimen versus a CNI-based regimen: a systematic review and meta-analysis of …
SG Mallat, BY Tanios, HS Itani, T Lotfi, C McMullan, S Gabardi, EA Akl, ...
Clinical Journal of the American Society of Nephrology 12 (8), 1321-1336, 2017
Integrated kidney exosome analysis for the detection of kidney transplant rejection
J Park, HY Lin, JP Assaker, S Jeong, CH Huang, A Kurdi, K Lee, K Fraser, ...
ACS nano 11 (11), 11041-11046, 2017
Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site
M Ben Nasr, A Vergani, J Avruch, L Liu, E Kefaloyianni, F D’Addio, ...
Acta diabetologica 52, 917-927, 2015
Polylactide-cyclosporin A nanoparticles for targeted immunosuppression
J Azzi, L Tang, R Moore, R Tong, N El Haddad, T Akiyoshi, B Mfarrej, ...
The FASEB Journal 24 (10), 3927, 2010
Targeted delivery of immunomodulators to lymph nodes
J Azzi, Q Yin, M Uehara, S Ohori, L Tang, K Cai, T Ichimura, M McGrath, ...
Cell reports 15 (6), 1202-1213, 2016
Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression
Y Kawano, O Zavidij, J Park, M Moschetta, K Kokubun, TH Mouhieddine, ...
The Journal of clinical investigation 128 (6), 2487-2499, 2018
Antibody-dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab
AT Kurdi, SV Glavey, NA Bezman, A Jhatakia, JL Guerriero, S Manier, ...
Molecular cancer therapeutics 17 (7), 1454-1463, 2018
A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection
MM Kaminski, MA Alcantar, IT Lape, R Greensmith, AC Huske, JA Valeri, ...
Nature biomedical engineering 4 (6), 601-609, 2020
Multiple myeloma and the immune microenvironment
Y Kawano, M Roccaro, I M Ghobrial, J Azzi
Current cancer drug targets 17 (9), 806-818, 2017
Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival
B Bahmani, M Uehara, L Jiang, F Ordikhani, N Banouni, T Ichimura, ...
The Journal of clinical investigation 128 (11), 4770-4786, 2018
PI3kα and STAT1 interplay regulates human mesenchymal stem cell immune polarization
M Mounayar, E Kefaloyianni, B Smith, Z Solhjou, OH Maarouf, J Azzi, ...
Stem cells 33 (6), 1892-1901, 2015
Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts
LV Riella, T Watanabe, PT Sage, J Yang, M Yeung, J Azzi, V Vanguri, ...
American journal of transplantation 11 (4), 832-840, 2011
Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice
E Sula Karreci, H Fan, M Uehara, AB Mihali, PK Singh, AT Kurdi, ...
Proceedings of the National Academy of Sciences 113 (52), E8425-E8432, 2016
Mesenchymal stem cells express serine protease inhibitor to evade the host immune response
N El Haddad, D Heathcote, R Moore, S Yang, J Azzi, B Mfarrej, ...
Blood, The Journal of the American Society of Hematology 117 (4), 1176-1183, 2011
Association of sirolimus use with risk for skin cancer in a mixed-organ cohort of solid-organ transplant recipients with a history of cancer
PS Karia, JR Azzi, EC Heher, VM Hills, CD Schmults
JAMA dermatology 152 (5), 533-540, 2016
The system can't perform the operation now. Try again later.
Articles 1–20